OmixMe provides a personalized genetic analysis of your sample and offers structured information about your genetic profile exclusively for informational purposes.
Disclaimer: This analysis does not represent a medical diagnosis or medical assessment. The results may serve as one of the informational bases for healthcare professionals in clinical consultations. Any decisions regarding healthcare remain the exclusive responsibility of qualified healthcare professionals; this service does not recommend or prescribe any treatment.
Four considerations where molecular biology may offer additional insight alongside standard approaches in cancer care.
Evaluation of biological samples provides an informational report on selected biological indicators without diagnostic or therapeutic purpose. Further analysis may provide additional information to support informed discussion with qualified healthcare professionals about individual circumstances.
People with the same diagnosis may have different molecular profiles. Without a deeper molecular view, the full picture of the molecular causes of biological response variability may be missing. Treatment response is a complex phenomenon dependent on multiple factors. Analysis of molecular markers helps understand the biology of a specific patient.
Understanding the available information from sample analysis may require time and discussion with a healthcare professional. Molecular information from sample analysis can serve as a basis for discussion with a doctor and can contribute to understanding the situation.
A large share of trials work with molecular criteria that hospitals do not routinely generate. With OmixMe data, your eligibility for specific trials can be assessed with greater detail and additional molecular information.
Disclaimer: The service is for informational purposes only, is not for diagnosis or treatment, and does not replace consultation with a physician or healthcare provider. Any treatment decision must be made by a qualified healthcare professional.
We combine deep DNA sequencing, analysis of liquid biopsy samples, and AI-driven assessment of the molecular state of samples to provide your oncologist with a molecular GPS for an informational report.
We sequence cancer-relevant genes and analyse RNA expression so your doctor can see molecular signals complementary to standard biopsies.
Sequencing and analysis of an individual's entire DNA, focused on genetic variants and genomic changes relevant in an oncology context.
AI + Human is used to assess the molecular state of samples provided by the client.
Disclaimer: The results are for informational purposes only and serve as a basis for discussion with a physician. The analysis is not a medical diagnosis and does not replace a medical consultation.
The process is simple and transparent:
Under ideal conditions, the client's doctor will receive the completed molecular analysis within approximately 14–30 days of receiving and confirming the tumour sample for processing.
Clear, usable outputs for your doctor or healthcare professional, prepared within weeks.
Detailed molecular analysis prepared for the physician — provides depth and evidence that can be given to your healthcare professional as a basis for their professional evaluation during the evaluation process.
At your request and with your consent, we will share the results with your oncologist. An external laboratory partner processes the sample and data in accordance with data protection rules. We will provide your oncologist with a comprehensive analysis of selected biological indicators to help him set up a therapy that may be more suitable based on the characteristics of the tumour for a specific tumour in a particular patient.
Sequenced from your tumour. DNA, RNA expression and ctDNA in one panel.
From receipt of the sample to the report in 2 weeks to 1 month — the processing timeframe.
Standard chemotherapy
Clinical data show varying effectiveness of treatment approaches depending on the molecular characteristics of the tumour.
Targeted therapy against specific molecular targets
Across well-validated targets such as EGFR, ALK and BRAF.
Sources: JCO Precision Oncology (2021) · Therapeutic Advances in Medical Oncology (2022).
Sample collection, sequencing, AI report, written report, expert consultation, and direct dialogue with your oncologist. Whether your tumour sample is 30 mg, 500 mg, or just a 10 mL blood draw — the process is the same.
Once you provide us with relevant information about your health background, we will prepare an individual price quote. The output report is for informational purposes only and does not replace a consultation with your doctor or oncologist.
Connect us with Your doctorWe take care of the logistics, sample processing and preparation of the informational report. You and your family can focus on what matters.
Our service focuses on multi-omic analysis of biological biomarkers relevant to oncology. We analyse the sample and provide a structured report with data relevant in the field of oncological multi-omics.
OmixMe helps clients gain:
This approach helps clarify the biological nature of the disease and can serve as an informational basis for discussions with a specialist.
Disclaimer: The OmixMe service does not establish a diagnosis. It is not a medical device or healthcare service. It does not replace a medical consultation. The output is for informational and educational purposes only. It is not intended as a basis for self-diagnosis or for making treatment decisions without medical supervision.
Simply connect us with Your oncologist and our team will send them all the necessary information with your consent.
Connect us with Your doctorOmixMe is built on Sameta Biomedical — a world-class team of bioinformaticians, AI engineers and molecular medicine experts with decades of experience in biotechnology and clinical research. To ensure high-quality analysis with rigorous processing of samples and data based on scientific knowledge in the field of multi-omics, the methodology is designed according to reliable principles with the latest insights from oncology research — we combine advanced data science with knowledge from oncology research to provide information.
Director of the Cancer Research Institute at the Biomedical Research Center of the Slovak Academy of Sciences, public research institution.
Contact us
contact@omixme.comSamples are analyzed by an experienced team, which subsequently verifies the correctness of the procedure.
Disclaimer: The processing of genetic and health data is subject to GDPR and data protection laws. Collection and laboratory processing are provided by a certified external partner. The OmixMe service is not a medical device, is not healthcare and does not establish any diagnosis. The service is intended for informational purposes only and does not replace a medical consultation.
"I've heard about personalized medicine and biomarker testing by OmixMe. I would like to have my tumour sample analysed so we can consider available options for personalising treatment based on molecular profiling."
"Could we consider whether the analysis results could help as an informational basis for the options of my cancer treatment?"
And if you'd rather we coordinate with your oncologist directly — that's exactly what we do.
If yours isn't here, ask us via email below. We answer every email in person.
Within a few days, you will receive an analytical report with information about the molecular properties of your sample — information that is for informational purposes only and is not for making treatment decisions without consulting a doctor.
Connect us with Your doctorWe coordinate with your treating oncologist directly. No commitment required.
Disclaimer: We process personal data in accordance with GDPR. The output is for informational purposes only and is not healthcare.
Email us and we will connect with your treating oncologist to assess whether OmixMe is the right service for obtaining information for further discussion.
Rapid Reporting
Accelerated process so your doctor receives the report as soon as possible.
Confidential & Secure
Your personal data from sample analysis remains private and is never shared without your explicit consent.
Transparent, Fixed Pricing
Comprehensive quote with no commitment and no hidden costs.
Doctor-first
Every analysis result is processed through your oncologist and delivered to them — they remain your primary medical contact.
Disclaimer: The service is for informational purposes only, is not for diagnosis or treatment, and does not replace consultation with a physician or healthcare provider. Any treatment decision must be made by a qualified healthcare professional.
